1. Home
  2. IVVD vs SMTI Comparison

IVVD vs SMTI Comparison

Compare IVVD & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$0.53

Market Cap

201.9M

Sector

Health Care

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$33.87

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVVD
SMTI
Founded
2020
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.9M
208.2M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
IVVD
SMTI
Price
$0.53
$33.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$8.75
$34.00
AVG Volume (30 Days)
3.3M
227.1K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
79.02
N/A
EPS
N/A
0.05
Revenue
$53,426,000.00
$15,586,976.00
Revenue This Year
$61.57
$17.31
Revenue Next Year
$41.42
$12.48
P/E Ratio
N/A
$681.20
Revenue Growth
110.47
32.47
52 Week Low
$0.49
$16.05
52 Week High
$3.07
$35.70

Technical Indicators

Market Signals
Indicator
IVVD
SMTI
Relative Strength Index (RSI) 29.09 82.32
Support Level N/A $20.47
Resistance Level $1.01 N/A
Average True Range (ATR) 0.05 1.26
MACD -0.01 0.87
Stochastic Oscillator 7.85 96.44

Price Performance

Historical Comparison
IVVD
SMTI

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: